Advertisement
Screener

Arcus Biosciences, Inc. (RCUS) Pre-Tax Margin

Arcus Biosciences, Inc. (RCUS) Pre-Tax Margin

  • 2026-06-30: Pre-Tax Margin -275.76%.
  • 2026-03-31: Pre-Tax Margin -1828.57%.
  • 2025-12-31: Pre-Tax Margin -963.64%.
  • 2025-09-30: Pre-Tax Margin -2250.00%.

Complete source-backed pre-tax margin history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Pre-Tax Margin

DatePre-Tax Margin
2026-06-30-275.76%
2026-03-31-1828.57%
2025-12-31-963.64%
2025-09-30-2250.00%
2025-06-300.00%
2025-03-31-1400.00%
2024-12-31-404.35%
2024-09-30-1314.29%
2024-06-30-845.45%
2024-03-31-40.00%
2023-12-31163.27%
2023-09-30-215.63%
2023-06-30-255.17%
2023-03-31-312.00%
2022-12-31167.50%
2022-09-30-196.97%
2022-06-30-248.15%
2022-03-31-372.22%
2021-12-3179.39%
2021-09-30-824.17%
2021-06-30-802.98%
2021-03-31-767.29%

Annual Pre-Tax Margin

DatePre-Tax Margin
2025-12-31-1069.70%
2024-12-31-552.94%
2023-12-31-813.51%
2022-12-31-700.00%
2021-12-3114.36%
2020-12-31-157.69%
2019-12-31-564.73%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Dyne Therapeutics, Inc. (DYN)United States$3.084B-7.09
Arcutis Biotherapeutics, Inc. (ARQT)United States$3.303B115.47
Enliven Therapeutics, Inc. (ELVN)United States$3.307B-35.07
Amylyx Pharmaceuticals, Inc. (AMLX)United States$3.361B-13.15
IDEAYA Biosciences, Inc. (IDYA)United States$3.540B-20.52
Organon & Co. (OGN)United States$3.603B17.03
PRECIGEN, INC. (PGEN)United States$2.757B-12.94
NewAmsterdam Pharma Co N.V. (NAMS)$2.719B-15.37
Xenon Pharmaceuticals Inc. (XENE)$3.684B-14.27
MBX Biosciences, Inc. (MBX)United States$2.664B-25.36